BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 6745994)

  • 1. IgM-RF prevents complement-mediated inhibition of immune precipitation.
    Mitchell WS; Naama JK; Veitch J; Whaley K
    Immunology; 1984 Jul; 52(3):445-8. PubMed ID: 6745994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation.
    Balestrieri G; Tincani A; Migliorini P; Ferri C; Cattaneo R; Bombardieri S
    Arthritis Rheum; 1984 Oct; 27(10):1130-6. PubMed ID: 6435641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
    O'Sullivan MM; Amos N; Williams BD
    Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
    Naama JK; Mitchell WS; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of Clq binding activity by IgM rheumatoid factor.
    Zilberfarb JL; Andrews BS; Young AC; Davis JS
    J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
    Doekes G; Schouten J; Cats A; Daha MR
    Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis.
    Kerr MA; Wilton E; Naama JK; Whaley K
    Clin Exp Immunol; 1986 Feb; 63(2):359-66. PubMed ID: 3698338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.
    Wagner T; Abraham G; Baum J
    J Clin Invest; 1974 Jun; 53(6):1503-11. PubMed ID: 4133792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid factors in the pathogenesis of rheumatoid arthritis.
    Mannik M
    J Rheumatol Suppl; 1992 Jan; 32():46-9. PubMed ID: 1613732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
    Scott DG; Bacon PA; Allen C; Elson CJ; Wallington T
    Clin Exp Immunol; 1981 Jan; 43(1):54-63. PubMed ID: 7249394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influences of rheumatoid factors on solubilization of precipitating immune complex due to complement].
    Hirose S; Saito K; Yukiyama Y; Ishii N
    Ryumachi; 1982 Aug; 22(4):308-14. PubMed ID: 7179026
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of IgM-rheumatoid factor interference in the determination of total serum IgE and IgE-containing circulating immune complexes.
    De Clerck LS; Gigase PL; Bridts CH; Stevens WJ
    Clin Exp Immunol; 1988 Apr; 72(1):32-6. PubMed ID: 3396220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of an inhibitor of complement-mediated prevention of immune precipitation.
    Ahmed AE; Veitch J; Whaley K
    Immunology; 1990 Jun; 70(2):139-44. PubMed ID: 2373514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.
    Lorber M; Samuel D; Amlot P; Panayi GS
    Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes and rheumatoid arthritis.
    Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
    J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.
    Naama JK; Mitchell WS; Zoma A; Veitch J; Whaley K
    Clin Exp Immunol; 1983 Feb; 51(2):292-8. PubMed ID: 6220848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
    Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
    Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of the rheumatoid factor on fixation of immune complex-complement complex on erythrocytes].
    Hirose S; Yukiyama Y; Saito K; Ishii N
    Ryumachi; 1983 Jun; 23(3):135-40. PubMed ID: 6623211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.